title: Changes for clozapine monitoring in the United States.
authors.affiliation: SAHMRI- Mind and Brain Research Fellow, Adelaide, SA, Australia.|Mental Health Strategy, SA Health, Govt. of South Australia, Adelaide, SA, Australia.|Department of Psychiatry, Flinders University, Adelaide, SA, Australia.
authors.forename: T
authors.initials: T
authors.lastname: Bastiampillai
authors.affiliation: Department of Psychiatry, Flinders Medical Centre, Bedford Park, Adelaide, SA, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Gupta
authors.affiliation: Department of Psychiatry, The University of Hong Kong, Hong Kong.|The State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong.
authors.forename: S K W
authors.initials: SK
authors.lastname: Chan
authors.affiliation: Discipline of Psychiatry, School of Medicine, Flinders University, Adelaide, SA, Australia.
authors.forename: S
authors.initials: S
authors.lastname: Allison
mesh_terms: D000380:Agranulocytosis / Q000378:metabolism; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003024:Clozapine / Q000494:pharmacology* / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy; D014481:United States
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine